Literature DB >> 17845154

Placental anomalies in children with infantile hemangioma.

Juan Carlos López Gutiérrez1, Luis Felipe Avila, Grevelyn Sosa, Mercedes Patron.   

Abstract

Evaluation of the placenta provides some important insights into pathophysiologic changes that take place during the prenatal and intrapartum process. We investigated the pathogenic significance of placental features and their relationship to the development of infantile hemangioma in order to obtain a better understanding of its cause. Placental specimens were reviewed from 26 singleton pregnancies of women whose offspring weighed less than 1500 g. A group of 13 neonates who developed infantile hemangioma in the immediate neonate period were compared with 13 healthy preterm infants of comparable postconception age who had no infantile hemangioma. Pathologic placental changes were analyzed in both groups. Gross lesions with disturbance of the utero-placental circulation were found in all placentas from children who developed infantile hemangioma, including massive retroplacental hematoma in two infants, extensive ischemic infarction in seven, and large dilatated vascular communications, severe vasculitis, chorioamnionitis and funiculitis in four. Placental features included percentages greater than 25% of avascular villi, platelet and fibrin aggregates, and multifocal disease involving more than one histologic section. Examination of 13 placentas of low-birth-weight infants without infantile hemangioma only showed abnormal placentation in one and isolated villous dismaturity in two. The higher ratio of placental pathologic findings in patients with infantile hemangioma suggests that reduced placental oxygen diffusive conductance contributes to fetal hypoxic stress and that hypoxic/ischemic changes in the placenta could be related to infantile hemangioma development via vascular endothelial growth factor and placental growth factor expression, among others, within the villious vessels and throphoblasts.

Entities:  

Mesh:

Year:  2007        PMID: 17845154     DOI: 10.1111/j.1525-1470.2007.00450.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  6 in total

1.  A potential role for notch signaling in the pathogenesis and regulation of hemangiomas.

Authors:  June K Wu; Jan K Kitajewski
Journal:  J Craniofac Surg       Date:  2009-03       Impact factor: 1.046

Review 2.  Cardiovascular drugs in the treatment of infantile hemangioma.

Authors:  Israel Fernandez-Pineda; Regan Williams; Lucia Ortega-Laureano; Ryan Jones
Journal:  World J Cardiol       Date:  2016-01-26

3.  Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies.

Authors:  A Munden; R Butschek; W L Tom; J S Marshall; D M Poeltler; S E Krohne; A B Alió; M Ritter; D F Friedlander; V Catanzarite; A Mendoza; L Smith; M Friedlander; S F Friedlander
Journal:  Br J Dermatol       Date:  2014-04       Impact factor: 9.302

4.  Infantile hemangiomas β3-adrenoceptor overexpression is associated with nonresponse to propranolol.

Authors:  Andrea Bassi; Cesare Filippeschi; Teresa Oranges; Chiara Caporalini; Alessandro Pini; Patrizia Nardini; Roberta Marie Gentile; Luca Filippi
Journal:  Pediatr Res       Date:  2021-03-02       Impact factor: 3.756

5.  Exploring the association between chorangioma and infantile haemangioma in singleton and multiple pregnancies: a case-control study in a Swedish tertiary centre.

Authors:  Meeli Sirotkina; Konstantinos Douroudis; Carl-Fredrik Wahlgren; Magnus Westgren; Nikos Papadogiannakis
Journal:  BMJ Open       Date:  2017-09-03       Impact factor: 2.692

Review 6.  Current perspectives on the optimal management of infantile hemangioma.

Authors:  Peter Grzesik; June K Wu
Journal:  Pediatric Health Med Ther       Date:  2017-12-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.